Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1548680

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1548680

North America Clinical Risk Grouping Solution Market Size, Share & Trends Analysis Report By Product (Software and Services), By End-use, By Deployment, By Application, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 127 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The North America Clinical Risk Grouping Solution Market would witness market growth of 12.4% CAGR during the forecast period (2024-2031).

The US market dominated the North America Clinical Risk Grouping Solution Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $489.8 million by 2031. The Canada market is experiencing a CAGR of 14.8% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 13.9% during (2024 - 2031).

A clinical risk grouping solution is a healthcare technology tool designed to categorize or "group" patients based on their risk of experiencing certain health outcomes, such as complications, hospitalizations, or the progression of chronic diseases.

Additionally, these solutions use various data inputs, including electronic health records (EHRs), claims data, demographic information, and sometimes social determinants of health, to analyze and stratify patients according to their risk levels.

North American healthcare providers are increasingly adopting these solutions to enhance patient outcomes, reduce healthcare costs, and comply with government regulations. Furthermore, the growing incidence of chronic diseases in the United States is a significant factor that is driving the demand for clinical risk classification systems. According to the Centers for Disease Control and Prevention (CDC), chronic disease affects 6 in 10 adults in the US, while 4 in 10 adults live with multiple chronic diseases. Chronic diseases represent one of the nation's leading causes of disability and drivers of the nation's $4.1 trillion in annual healthcare spending.

Based on Product, the market is segmented into Software and Services. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, Long Term Care Centers, and Other. Based on Deployment, the market is segmented into Private Cloud, Public Cloud, and Hybrid Cloud. Based on Application, the market is segmented into Population Health Management, Chronic Disease Management, Clinical Decision Support, Fraud Detection and Prevention, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

  • Conduent, Incorporated
  • 3M Company
  • Oracle Corporation (Cerner Corporation)
  • Microsoft Corporation (Nuance Communications, Inc.)
  • Health Catalyst, Inc.
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG (Siemens AG)
  • HBI Solutions
  • Lightbeam Health Solutions
  • Reveleer

North America Clinical Risk Grouping Solution Market Report Segmentation

By Product

  • Software
  • Services

By End-use

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Long Term Care Centers
  • Other

By Deployment

  • Private Cloud
  • Public Cloud
  • Hybrid Cloud

By Application

  • Population Health Management
  • Chronic Disease Management
  • Clinical Decision Support
  • Fraud Detection and Prevention
  • Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 North America Clinical Risk Grouping Solution Market, by Product
    • 1.4.2 North America Clinical Risk Grouping Solution Market, by End-use
    • 1.4.3 North America Clinical Risk Grouping Solution Market, by Deployment
    • 1.4.4 North America Clinical Risk Grouping Solution Market, by Application
    • 1.4.5 North America Clinical Risk Grouping Solution Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities:
    • 3.2.4 Market Challenges:

Chapter 4. Competition Analysis - Global

  • 4.1 KBV Cardinal Matrix
  • 4.2 Recent Industry Wide Strategic Developments
    • 4.2.1 Partnerships, Collaborations and Agreements
    • 4.2.2 Product Launches and Product Expansions
    • 4.2.3 Acquisition and Mergers
  • 4.3 Market Share Analysis, 2023
  • 4.4 Top Winning Strategies
    • 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
    • 4.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2021, Mar - 2024, Apr) Leading Players
  • 4.5 Porter Five Forces Analysis

Chapter 5. North America Clinical Risk Grouping Solution Market by Product

  • 5.1 North America Software Market by Region
  • 5.2 North America Services Market by Region

Chapter 6. North America Clinical Risk Grouping Solution Market by End-use

  • 6.1 North America Hospitals & Clinics Market by Country
  • 6.2 North America Ambulatory Surgical Centers Market by Country
  • 6.3 North America Long Term Care Centers Market by Country
  • 6.4 North America Other Market by Country

Chapter 7. North America Clinical Risk Grouping Solution Market by Deployment

  • 7.1 North America Private Cloud Market by Country
  • 7.2 North America Public Cloud Market by Country
  • 7.3 North America Hybrid Cloud Market by Country

Chapter 8. North America Clinical Risk Grouping Solution Market by Application

  • 8.1 North America Population Health Management Market by Country
  • 8.2 North America Chronic Disease Management Market by Country
  • 8.3 North America Clinical Decision Support Market by Country
  • 8.4 North America Fraud Detection and Prevention Market by Country
  • 8.5 North America Others Market by Country

Chapter 9. North America Clinical Risk Grouping Solution Market by Country

  • 9.1 US Clinical Risk Grouping Solution Market
    • 9.1.1 US Clinical Risk Grouping Solution Market by Product
    • 9.1.2 US Clinical Risk Grouping Solution Market by End-use
    • 9.1.3 US Clinical Risk Grouping Solution Market by Deployment
    • 9.1.4 US Clinical Risk Grouping Solution Market by Application
  • 9.2 Canada Clinical Risk Grouping Solution Market
    • 9.2.1 Canada Clinical Risk Grouping Solution Market by Product
    • 9.2.2 Canada Clinical Risk Grouping Solution Market by End-use
    • 9.2.3 Canada Clinical Risk Grouping Solution Market by Deployment
    • 9.2.4 Canada Clinical Risk Grouping Solution Market by Application
  • 9.3 Mexico Clinical Risk Grouping Solution Market
    • 9.3.1 Mexico Clinical Risk Grouping Solution Market by Product
    • 9.3.2 Mexico Clinical Risk Grouping Solution Market by End-use
    • 9.3.3 Mexico Clinical Risk Grouping Solution Market by Deployment
    • 9.3.4 Mexico Clinical Risk Grouping Solution Market by Application
  • 9.4 Rest of North America Clinical Risk Grouping Solution Market
    • 9.4.1 Rest of North America Clinical Risk Grouping Solution Market by Product
    • 9.4.2 Rest of North America Clinical Risk Grouping Solution Market by End-use
    • 9.4.3 Rest of North America Clinical Risk Grouping Solution Market by Deployment
    • 9.4.4 Rest of North America Clinical Risk Grouping Solution Market by Application

Chapter 10. Company Profiles

  • 10.1 Conduent, Incorporated
    • 10.1.1 Company Overview
    • 10.1.2 Financial Analysis
    • 10.1.3 Segmental and Regional Analysis
    • 10.1.4 Research & Development Expenses
  • 10.2 3M Company
    • 10.2.1 Company Overview
    • 10.2.2 Financial Analysis
    • 10.2.3 Segmental and Regional Analysis
    • 10.2.4 Research & Development Expense
    • 10.2.5 Recent strategies and developments:
      • 10.2.5.1 Product Launches and Product Expansions:
    • 10.2.6 SWOT Analysis
  • 10.3 Oracle Corporation (Cerner Corporation)
    • 10.3.1 Company Overview
    • 10.3.2 Financial Analysis
    • 10.3.3 Segmental and Regional Analysis
    • 10.3.4 Research & Development Expense
    • 10.3.5 Recent strategies and developments:
      • 10.3.5.1 Product Launches and Product Expansions:
    • 10.3.6 SWOT Analysis
  • 10.4 Microsoft Corporation (Nuance Communications, Inc.)
    • 10.4.1 Company Overview
    • 10.4.2 Financial Analysis
    • 10.4.3 Segmental and Regional Analysis
    • 10.4.4 Research & Development Expenses
    • 10.4.5 Recent strategies and developments:
      • 10.4.5.1 Product Launches and Product Expansions:
    • 10.4.6 SWOT Analysis
  • 10.5 Health Catalyst, Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Financial Analysis
    • 10.5.3 Segmental Analysis
    • 10.5.4 Research & Development Expenses
    • 10.5.5 Recent strategies and developments:
      • 10.5.5.1 Product Launches and Product Expansions:
      • 10.5.5.2 Acquisition and Mergers:
    • 10.5.6 SWOT Analysis
  • 10.6 Koninklijke Philips N.V.
    • 10.6.1 Company Overview
    • 10.6.2 Financial Analysis
    • 10.6.3 Segmental and Regional Analysis
    • 10.6.4 Research & Development Expense
    • 10.6.5 Recent strategies and developments:
      • 10.6.5.1 Product Launches and Product Expansions:
      • 10.6.5.2 Acquisition and Mergers:
    • 10.6.6 SWOT Analysis
  • 10.7 Siemens Healthineers AG (Siemens AG)
    • 10.7.1 Company Overview
    • 10.7.2 Financial Analysis
    • 10.7.3 Segmental and Regional Analysis
    • 10.7.4 Research & Development Expense
    • 10.7.5 SWOT Analysis
  • 10.8 HBI Solutions
    • 10.8.1 Company Overview
  • 10.9 Lightbeam Health Solutions
    • 10.9.1 Company Overview
    • 10.9.2 Recent strategies and developments:
      • 10.9.2.1 Partnerships, Collaborations, and Agreements:
      • 10.9.2.2 Acquisition and Mergers:
  • 10.10. Reveleer
    • 10.10.1 Company Overview
    • 10.10.2 Recent strategies and developments:
      • 10.10.2.1 Acquisition and Mergers:

LIST OF TABLES

  • TABLE 1 North America Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
  • TABLE 2 North America Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Enterprise Key Management Market
  • TABLE 4 Product Launches And Product Expansions- Enterprise Key Management Market
  • TABLE 5 Acquisition and Mergers- Enterprise Key Management Market
  • TABLE 6 North America Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
  • TABLE 7 North America Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
  • TABLE 8 North America Software Market by Region, 2020 - 2023, USD Million
  • TABLE 9 North America Software Market by Region, 2024 - 2031, USD Million
  • TABLE 10 North America Services Market by Region, 2020 - 2023, USD Million
  • TABLE 11 North America Services Market by Region, 2024 - 2031, USD Million
  • TABLE 12 North America Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
  • TABLE 13 North America Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
  • TABLE 14 North America Hospitals & Clinics Market by Country, 2020 - 2023, USD Million
  • TABLE 15 North America Hospitals & Clinics Market by Country, 2024 - 2031, USD Million
  • TABLE 16 North America Ambulatory Surgical Centers Market by Country, 2020 - 2023, USD Million
  • TABLE 17 North America Ambulatory Surgical Centers Market by Country, 2024 - 2031, USD Million
  • TABLE 18 North America Long Term Care Centers Market by Country, 2020 - 2023, USD Million
  • TABLE 19 North America Long Term Care Centers Market by Country, 2024 - 2031, USD Million
  • TABLE 20 North America Other Market by Country, 2020 - 2023, USD Million
  • TABLE 21 North America Other Market by Country, 2024 - 2031, USD Million
  • TABLE 22 North America Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
  • TABLE 23 North America Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
  • TABLE 24 North America Private Cloud Market by Country, 2020 - 2023, USD Million
  • TABLE 25 North America Private Cloud Market by Country, 2024 - 2031, USD Million
  • TABLE 26 North America Public Cloud Market by Country, 2020 - 2023, USD Million
  • TABLE 27 North America Public Cloud Market by Country, 2024 - 2031, USD Million
  • TABLE 28 North America Hybrid Cloud Market by Country, 2020 - 2023, USD Million
  • TABLE 29 North America Hybrid Cloud Market by Country, 2024 - 2031, USD Million
  • TABLE 30 North America Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
  • TABLE 31 North America Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
  • TABLE 32 North America Population Health Management Market by Country, 2020 - 2023, USD Million
  • TABLE 33 North America Population Health Management Market by Country, 2024 - 2031, USD Million
  • TABLE 34 North America Chronic Disease Management Market by Country, 2020 - 2023, USD Million
  • TABLE 35 North America Chronic Disease Management Market by Country, 2024 - 2031, USD Million
  • TABLE 36 North America Clinical Decision Support Market by Country, 2020 - 2023, USD Million
  • TABLE 37 North America Clinical Decision Support Market by Country, 2024 - 2031, USD Million
  • TABLE 38 North America Fraud Detection and Prevention Market by Country, 2020 - 2023, USD Million
  • TABLE 39 North America Fraud Detection and Prevention Market by Country, 2024 - 2031, USD Million
  • TABLE 40 North America Others Market by Country, 2020 - 2023, USD Million
  • TABLE 41 North America Others Market by Country, 2024 - 2031, USD Million
  • TABLE 42 North America Clinical Risk Grouping Solution Market by Country, 2020 - 2023, USD Million
  • TABLE 43 North America Clinical Risk Grouping Solution Market by Country, 2024 - 2031, USD Million
  • TABLE 44 US Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
  • TABLE 45 US Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
  • TABLE 46 US Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
  • TABLE 47 US Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
  • TABLE 48 US Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
  • TABLE 49 US Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
  • TABLE 50 US Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
  • TABLE 51 US Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
  • TABLE 52 US Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
  • TABLE 53 US Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
  • TABLE 54 Canada Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
  • TABLE 55 Canada Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
  • TABLE 56 Canada Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
  • TABLE 57 Canada Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
  • TABLE 58 Canada Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
  • TABLE 59 Canada Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
  • TABLE 60 Canada Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
  • TABLE 61 Canada Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
  • TABLE 62 Canada Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
  • TABLE 63 Canada Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
  • TABLE 64 Mexico Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
  • TABLE 65 Mexico Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
  • TABLE 66 Mexico Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
  • TABLE 67 Mexico Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
  • TABLE 68 Mexico Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
  • TABLE 69 Mexico Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
  • TABLE 70 Mexico Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
  • TABLE 71 Mexico Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
  • TABLE 72 Mexico Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
  • TABLE 73 Mexico Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
  • TABLE 74 Rest of North America Clinical Risk Grouping Solution Market, 2020 - 2023, USD Million
  • TABLE 75 Rest of North America Clinical Risk Grouping Solution Market, 2024 - 2031, USD Million
  • TABLE 76 Rest of North America Clinical Risk Grouping Solution Market by Product, 2020 - 2023, USD Million
  • TABLE 77 Rest of North America Clinical Risk Grouping Solution Market by Product, 2024 - 2031, USD Million
  • TABLE 78 Rest of North America Clinical Risk Grouping Solution Market by End-use, 2020 - 2023, USD Million
  • TABLE 79 Rest of North America Clinical Risk Grouping Solution Market by End-use, 2024 - 2031, USD Million
  • TABLE 80 Rest of North America Clinical Risk Grouping Solution Market by Deployment, 2020 - 2023, USD Million
  • TABLE 81 Rest of North America Clinical Risk Grouping Solution Market by Deployment, 2024 - 2031, USD Million
  • TABLE 82 Rest of North America Clinical Risk Grouping Solution Market by Application, 2020 - 2023, USD Million
  • TABLE 83 Rest of North America Clinical Risk Grouping Solution Market by Application, 2024 - 2031, USD Million
  • TABLE 84 Key Information -Conduent, Incorporated
  • TABLE 85 Key Information - 3M Company
  • TABLE 86 Key Information - Oracle Corporation
  • TABLE 87 Key Information - Microsoft Corporation
  • TABLE 88 Key Information - Health Catalyst, Inc.
  • TABLE 89 Key Information - Koninklijke Philips N.V.
  • TABLE 90 Key Information - Siemens Healthineers AG
  • TABLE 91 Key Information - HBI Solutions
  • TABLE 92 Key Information - Lightbeam Health Solutions
  • TABLE 93 Key Information - Reveleer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!